Congress theme: Ensuring Safety, Advancing Science: Bridging to the Future with NAMs
Provisionally accepted sessions with oral presentations, based on the ESTIV2026 call for session.
(Notification of the acceptance/rejection of the proposal were sent on 15 May 2025)
| Beyond Positive Results: Interpreting NAMs for Endocrine Disruptors |
| Replacing the use of animals in therapeutic monoclonal antibody drug approvals |
| We Know Many of the Barriers to Adoption of NAMs, but What are the Solutions? |
| Update to OECD Guidance Document 34 on the validation of methods and Defined Approaches |
| Complex chemical mixtures across the environment-food-human continuum |
| Advancing the Use of NAMs in Food Safety: Innovations, Challenges, and Future Directions |
| Emerging researchers of the ASPIS Academy, PARC Junior Community, and VICT3R ESR |
| International Standards as the Bridge to the Future of Safe Medical Devices |
| Evolution of an OECD Test Guideline and Application Beyond; Integrated NAMs for Skin Sensitisation Hazard and Point of Departure for Risk Assessment |
| Guidance for In Vitro Air-Liquid interface Inhalation Toxicity Assessment |
| From Research to Regulation: standardising innovative non-animal technologies |
| Development and Regulatory Acceptance of NAMs in Genetic Toxicology |
| Towards robust and reliable in vitro models for Developmental and Reproductive toxicology |
| The application and standardisation of in vitro inhalation toxicology methods for academia and industry |
| NAMs in Cardiac Safety |
| Ensuring Safety of Food Nanomaterials: Bridging Microbiota to Health with NAMs. |
| State of the art of in vitro DART assays: The bigger picture |
| AI-Powered Toxicity Screening: Enhancing In Vitro Models, 3Rs, and Regulatory Adoption. |
| Advances and Challenges in the Acceptance of High Throughput Transcriptomics for Risk Assessment |
| VHP4Safety: how to move towards next-generation safety assessment based on human data? |
| Systemic Effects Evaluation Using NAM Toolboxes: Key Lessons Learned from Real-World Cases |
| Multimodal Modeling of the Gut Compartment – NAMs for Food Safety |
| Parameterization of Physiologically-based Pharmacokinetics (PBPK) Modelling for NGRA: Designed to be Protective |
ESTIV 2026 – Poster session topics
- Bio-engineering, stem cells and disease models
- Models, biomarkers and assays for endocrine disruption
- Models, biomarkers and assays for systemic and immune toxicity
- Models, biomarkers and assays for developmental toxicity
- Cardiotoxicity and cardiac efficacy models
- Local toxicity testing (safety and efficacy)
- Case studies for successful use and implementation of complex in vitro models
- Challenges in cosmetics safety
- Organ-on-a-chip & Microphysiological Systems
- Regulatory considerations for complex NAMs
- Computational toxicology – in silico modelling, read-across, artificial intelligence and machine learning
- Toxicokinetics and in vitro – in vivo extrapolation
- In vitro systems to assess respiratory toxicity
- Non-animal methods for safety testing of biopharmaceuticals/biotherapies/vaccines
- Serum free approaches
- Knowledge sharing and education
- Funding the development, validation and implementation of NAMs
- ECHA, EMA and EFSA perspectives on the use of NAMs
- In vitro and in silico methods for safety assessment of medical devices
- Role of 3R centres in the dissemination and implementation of NAMs
- Other
In contrast to previous years, we invite you to submit your session proposals that align with the congress theme:
“Ensuring Safety, Advancing Science: Bridging to the Future with NAMs”
You can enter the form to complete your prosal via the button below. Presenting authors will have the opportunity to prepare original research manuscripts or review papers for consideration in the ESTIV 2026 proceedings, to be published in the journal Toxicology In Vitro.
The deadline for session proposals is: Tuesday April 1, 2025 at 11:59am (CEST).
Draft Scientific Programme
The programme may still be subject to minor changes
Monday, June 29th, 2026
09:00-13:00: Pre-conference workshop
13:00-14:00: Lunch break
14:00-14:20: Opening Ceremony of the ESTIV 2026 Congress
Chairs: Dr Helena Kandarova (CEM SAS, Bratislava, Slovakia) & Dr Clive Roper (Roper Toxicology Consulting Limited, Edinburgh, UK)
14:20-15:00: Keynote lecture I
15:00-16:00 ESTIV Early Scientific Career Award ceremony 2026 and Lecture
Chairs: Dr Helena Kandarova (CEM SAS, Bratislava, Slovakia) & Dr Clive Roper (Roper Toxicology Consulting Limited, Edinburgh, UK)
16:00-16:30: Coffee break, visiting exhibition area & poster viewing
16:30-18:30: Session 1
18:30-20:00: Welcome reception & Poster session
Tuesday, June 30th, 2026
08:30-09:00 Keynote Lecture II
09:00-10:30: Session 2a
09:00-10:30: Session 2b
10:30-11:00: Coffee break, visiting exhibition area & poster viewing
11:00-13:00: Session 3a
11:00-13:00: Session 3b
13:00-14:00: Lunch break, visiting exhibition area & poster viewing
14:00-16:00: Session 4a
14:00-16:00: Session 4b
16:00-16:30: Coffee break, visiting exhibition area & poster viewing
16:30-17:30: Early Stage Researcher Session 1
16:30-17:30: Industry session
17:30-18:30: Early Stage Researcher Session 2
17:30-19:30: Peer Review for Validation Studies
18:30 – 19:30: ESTIV General Assembly
Poster Session
Wednesday, July 1st, 2026
08:30-09:00 Keynote Lecture III
09:00-10:30: Session 5a
09:00-10:30: Session 5b
10:30-11:00: Coffee break, visiting exhibition area & poster viewing
11:00-13:00: Session 6a
11:00-13:00 Session 6b
13:00-14:00: Lunch break, visiting exhibition area & poster viewing
14:00-15:00 Session 7a
14:00-15:00 Session 7b- Towards Liver models
15:00-16:00: Debate session and Panel discussion
16:00-16:30: Coffee break, visiting exhibition area & poster viewing
16:30-18:30: Session 8a
16:30-18:30: Session 8b
18:30 – 19:30 Career development session and poster session
19:30 – Departures to Congress dinner & social evening
Thursday, July 2nd, 2026
08:30 – 9:00 Keynote lecture IV
09:00-10:00: Session 9a
09:00-10:00: Session 9b
10:00-11:00: Session 10a
10:00-11:00: Early Stage Researcher Session 3
11:00-11:30: Coffee break
11:30-12:45: Session 11a
11:30 – 12:45: Session 11b
12:45-13:30: Congress closing ceremony
Chairs: Dr Helena Kandarova (CEM SAS, Bratislava, Slovakia) & Dr Clive Roper (Roper Toxicology Consulting Limited, Edinburgh, UK)
POST-CONFERENCE ACTIVITIES
14:00-19:00: Post-conference workshop
Friday, July 3rd, 2026
09:00-13:00: Post-conference workshop